#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leiomyosarcoma recurrent Dermatitis Blastic plasmacytoid dendritic cell neoplasia Nasopharyngeal cancer Glomerulonephritis Astrocytoma malignant Drug eruption Hyperadrenocorticism Gaucher's disease type I Hodgkin's disease Medulloblastoma recurrent Neurotrophic keratopathy Spinal cord injury cervical Methylmalonic acidaemia Haemophilia B with anti factor IX More trials…

    Learn about Rare Diseases

    Medulloblastoma recurrent – Basic Information Pleural mesothelioma malignant – Diagnostics Familial amyotrophic lateral sclerosis – Diagnostics Combined immunodeficiency – Life with Disease Rett syndrome Activated PI3 kinase delta syndrome – Treatment Waldenstrom’s macroglobulinaemia refractory – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Methylmalonic acidaemia Congenital generalised lipodystrophy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Flutamide Nivolumab Seralutinib Ecoo2 Bay 2927088 Fluciclovine (18F) Dnth103 VISUGROMAB Oxybuprocaine Hydrochloride Vsf1.01 Urapidil Ceftriaxone Rozanolixizumab L-Tyrosine Levamisole Hydrochloride Olanzapine Crovalimab Palopegteriparatide Romidepsin SODIUM BENZOATE More therapies…

    Learn about Your Condition

    Dent's disease Ovarian cancer stage IV Oropharyngeal cancer Adenomyosis Hodgkin's disease Psoriatic arthropathy Lymphangiosarcoma Hepatitis alcoholic Pyrexia Left ventricular dysfunction Castleman's disease Pharyngeal cancer stage I Addison's disease Intellectual disability Angelman's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Istituto Oncologico Veneto

Istituto Oncologico Veneto

Via Gattamelata 64, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of drug combination with gemcitabine, cisplatin, carboplatin and avelumab in patients with advanced urothelial cancer to evaluate response to platinum-based chemotherapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Avelumab
    • Carboplatin
    • Cisplatin
    Italy

  • Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Carboplatin
    • Infliximab
    • Mycophenolate Mofetil
    Austria Belgium Czechia France Germany Hungary +5

  • Study Comparing Ceralasertib and Durvalumab with Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Ceralasertib
    • Docetaxel
    • Durvalumab
    Belgium France Germany Hungary Ireland Italy +4

  • Study on How Concizumab Works for Patients with Hemophilia A or B with Inhibitors

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Haemophilia A with anti factor VIII
    • Haemophilia B with anti factor IX
    Investigated Drugs:
    • Concizumab
    Croatia Denmark France Italy Poland Portugal +2

  • Study on Atezolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer with Positive ctDNA After Surgery

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Atezolizumab
    Belgium Czechia France Germany Greece Ireland +3

  • Study of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma stage III
    • Malignant melanoma stage IV
    Investigated Drugs:
    • Nivolumab
    • Relatlimab
    Austria Belgium Czechia Denmark Finland France +7

  • Study on Durvalumab and Platinum-Based Drug Combination for Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Carboplatin
    • Cisplatin
    Austria Czechia France Germany Hungary Italy +3

  • Study Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Crizotinib
    • Entrectinib
    Croatia France Germany Greece Italy The Netherlands +4

  • Study on the Safety and Effectiveness of Pembrolizumab and Tretinoin in Patients with PD-1 Refractory Melanoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Favezelimab
    • Quavonlimab
    • Tretinoin
    France Greece Hungary Italy Poland Spain

  • Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bemarituzumab
    • Capecitabine
    • Fluorouracil
    Austria Belgium Bulgaria Czechia France Germany +6
Previous Page
1 … 28 29 30 31 32 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!